These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7932411)

  • 1. Anti-Ro(SSA) antibodies in patients with rheumatoid arthritis--a possible marker for gold induced side effects.
    Tishler M; Golbrut B; Shoenfeld Y; Yaron M
    J Rheumatol; 1994 Jun; 21(6):1040-2. PubMed ID: 7932411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster.
    Boire G; Ménard HA; Gendron M; Lussier A; Myhal D
    J Rheumatol; 1993 Oct; 20(10):1654-60. PubMed ID: 8295174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factors.
    Vlachoyiannopoulos PG; Zerva LV; Skopouli FN; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1991 Jan; 18(1):44-9. PubMed ID: 1827158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
    Tishler M; Moutsopoulos HM; Yaron M
    J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
    López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
    J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
    Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
    J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.
    Comby E; Tanaff P; Mariotte D; Costentin-Pignol V; Marcelli C; Ballet JJ
    J Rheumatol; 2006 Jan; 33(1):24-30. PubMed ID: 16395746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
    De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
    Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects.
    Moutsopoulos HM; Skopouli FN; Sarras AK; Tsampoulas C; Mavridis AK; Constantopoulos SH; Maddison PJ
    Ann Rheum Dis; 1985 Apr; 44(4):215-9. PubMed ID: 3872635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects.
    Tishler M; Nyman J; Wahren M; Yaron M
    Rheumatol Int; 1997; 17(4):133-5. PubMed ID: 9440142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
    Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rare side effects of gold].
    Stollenwerk R; Annefeld M; Schilling F; Dreher R
    Z Rheumatol; 1986; 45(3):107-10. PubMed ID: 2944309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
    Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
    Hansen B; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases.
    García-de la Torre I; Sánchez-Guerrero A; Salmón-de la Torre G; Hernández-Vázquez L
    J Rheumatol; 1987 Jun; 14(3):479-81. PubMed ID: 3498034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.